(Q41677318)

6 October 2017

1 reference

title

Migraine and migraine variants in childhood and adolescence (English)

1 reference

6 October 2017

0 references

1 reference

Lewis DW

1

1 reference

6 October 2017

publication date

1 June 1995

1 reference

Seminars in pediatric neurology

6 October 2017

published in

1 reference

6 October 2017

volume

2

1 reference

6 October 2017

issue

2

1 reference

6 October 2017

page(s)

127-143

1 reference

Changes in the Prevalence of Migraine and Other Headaches During the First Seven School Years

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Some aspects of the epidemiology of migraine in Denmark

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

An epidemiologic study of migraine and headache in 10-20 year olds.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

The pontypridd headache survey.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

An update on the epidemiology of migraine

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Migraine and migrainous variants in pediatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Diagnosis and treatment of migraine in children

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Diagnoses and symptom patterns in children presenting to a pediatric headache clinic

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

International headache society criteria and childhood headache

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Migraine symptoms in school children: what is the best diagnostic characteristic for migraine?

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Pediatric headaches: a one year retrospective analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Headaches in Children: A Review

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Migraine headache in the infant and young child.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Migraine in the infant and toddler

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Visual symptoms in the migraine syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Basilar artery migraine. A review of 30 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Familial hemiplegic migraine--a reappraisal and a long-term follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

A gene for familial hemiplegic migraine maps to chromosome 19

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Alternating hemiplegia of childhood: studies of regional cerebral blood flow using 99mTc-hexamethylpropylene amine oxime single-photon emission computed tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Ophthalmoplegic migraine

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Recurrent Painless Oculomotor Palsy in Children. A Variant of Ophthalmopegic Migraine?

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Ophthalmoplegic migraine: ischemic or compressive neuropathy?

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Ophthalmoplegic migraine in infancy

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Steroid-responsive ophthalmoplegia in a child. Diagnostic considerations.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Ophthalmoplegia in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

1 reference

7 January 2021

Visual disturbances of migraine

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Neuro-ophthalmic complications of migraine and cluster headaches.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

The migrainous scotoma as studied in 618 persons

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Some clinical aspects of migraine. A prospective survey of 500 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

1 reference

7 January 2021

Migraine as a cause of benign paroxysmal vertigo of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

What does the headache patient want?

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Biofeedback and Headache

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Biofeedback and relaxation-response training in the treatment of pediatric migraine

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Behavioral assessment and treatment of child migraine: implications for clinical research and practice

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Is migraine food allergy? A double-blind controlled trial of oligoantigenic diet treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Tyramine sensitivity in dietary migraine: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Two Controlled Trials of Tyramine in Children with Migraine

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

A clinical study of tyramine as an etiological factor in migraine

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Dietary factors in migraine precipitation: the physicians' view

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Concomitant medical disease and headache

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Oral contraceptives and stroke in young women. Associated risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Pharmacologic treatment of childhood migraine

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Treatment of migraine with isometheptene, acetaminophen, and dichloralphenazone combination: a double-blind, crossover trial

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Treatment of migraine attacks with sumatriptan. The Subcutaneous Sumatriptan International Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Subcutaneous sumatriptan during the migraine aura

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

The safety and tolerability of sumatriptan: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Sumatriptan--an oral dose-defining study. The Oral Sumatriptan Dose-Defining Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Propanolol ('Inderal') in the treatment of childhood migraine

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

The calcium antagonist properties of cyproheptadine: implications for antimigraine action

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Amitriptyline in Migraine Prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

A placebo-controlled crossover trial of nimodipine in pediatric migraine

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Nifedipine versus propranolol for the initial prophylaxis of migraine.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Successful migraine prophylaxis with naproxen sodium

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Naproxen in prophylaxis of migraine

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Migraine in childhood and its prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

Management of migraine

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2805%2980023-3

7 January 2021

10.1016/S1071-9091(05)80023-3

Identifiers

DOI

1 reference

6 October 2017

1 reference